Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

Several spine and orthopedic companies have made progress with acquisitions in the first quarter of 2025. 1. Stryker has ...

The university said on March 21 that the motor function score for two patients improved after an operation to implant more than two million iPS-derived cells into a spinal cord. No serious adverse ...

The market’s growth is being propelled by cutting-edge technologies designed to meet individual patient needs. As healthcare providers prioritize improving treatment efficacy and patient outcomes, ...

Nevro NVRO is well-poised for growth in the ... However, concerns regarding softness in the spinal cord stimulation (SCS) market and dependence on third-party payers persist.

So, let’s take a look at the Value Grade for all of our stocks. InMode Ltd. stock has a Value Grade of B. Nevro Corp. stock has a Value Grade of B. DENTSPLY SIRONA Inc. stock has a Value Grade of B.

A combo of muscle-stimulating implant and robotic exoskeleton can help restore movement in spinal cord paralysis Five people were able to walk or ride a stationary bike using the combination Some ...

A muscle-stimulating implant combined with a robotic exoskeleton can help restore movement in people paralyzed by a spinal cord injury, a new study says. The spinal cord implant delivers well-timed ...

FRIDAY, March 14, 2025 (HealthDay News) -- A muscle-stimulating implant combined with a robotic exoskeleton can help restore movement in people paralyzed by a spinal cord injury, a new study says.